Combination Immunomodulator and Antibiotic Treatment in Patients With Inflammatory Bowel Disease and Clostridium difficile Infection
- 1 September 2009
- journal article
- research article
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 7 (9) , 981-987
- https://doi.org/10.1016/j.cgh.2009.05.031
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- A National Survey of the Prevalence and Impact of Clostridium difficile Infection Among Hospitalized Inflammatory Bowel Disease PatientsAmerican Journal of Gastroenterology, 2008
- Risk factors for the development of fulminant Clostridium difficile colitisSurgery, 2008
- Update on the changing epidemiology of Clostridium difficile-associated diseaseNature Clinical Practice Gastroenterology & Hepatology, 2008
- Outcomes of Clostridium difficile-Associated Disease Treated With Metronidazole or Vancomycin Before and After the Emergence of NAP1/027American Journal of Gastroenterology, 2007
- Association of proton-pump inhibitors with outcomes inClostridium difficilecolitisAmerican Journal of Health-System Pharmacy, 2007
- Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel diseaseGut, 2007
- Impact of Clostridium difficile on Inflammatory Bowel DiseaseClinical Gastroenterology and Hepatology, 2007
- Incidence of Clostridium difficile Infection in Inflammatory Bowel DiseaseClinical Gastroenterology and Hepatology, 2007
- The Diagnostic Yield of Stool Pathogen Studies During Relapses of Inflammatory Bowel DiseaseJournal of Clinical Gastroenterology, 2004
- Enteric infection in relapse of inflammatory bowel diseaseEuropean Journal of Gastroenterology & Hepatology, 2004